sj-docx-1-msj-10.1177_13524585211032348 – Supplemental material for Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing–remitting MS

Kuhle, Jens; Daizadeh, Nadia; Benkert, Pascal; Maceski, Aleksandra; Barro, Christian; Michalak, Zuzanna; Sormani, Maria Pia; Godin, Jean; Shankara, Srinivas; Samad, Tarek A; Jacobs, Alan; Chung, Luke; Rӧsch, Nora; Kaiser, Carina; Mitchell, Colin P; Leppert, David; Havari, Evis; Kappos, Ludwig

doi:10.25384/SAGE.15156647.v1

sj-docx-1-msj-10.1177_13524585211032348.docx (53.69 kB)

sj-docx-1-msj-10.1177_13524585211032348 – Supplemental material for Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing–remitting MS

journal contribution

posted on 2021-08-12, 12:07 authored by Jens Kuhle, Nadia Daizadeh, Pascal Benkert, Aleksandra Maceski, Christian Barro, Zuzanna Michalak, Maria Pia Sormani, Jean Godin, Srinivas Shankara, Tarek A Samad, Alan Jacobs, Luke Chung, Nora Rӧsch, Carina Kaiser, Colin P Mitchell, David Leppert, Evis Havari, Ludwig Kappos

Supplemental material, sj-docx-1-msj-10.1177_13524585211032348 for Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing–remitting MS by Jens Kuhle, Nadia Daizadeh, Pascal Benkert, Aleksandra Maceski, Christian Barro, Zuzanna Michalak, Maria Pia Sormani, Jean Godin, Srinivas Shankara, Tarek A Samad, Alan Jacobs, Luke Chung, Nora Rӧsch, Carina Kaiser, Colin P Mitchell, David Leppert, Evis Havari and Ludwig Kappos in Multiple Sclerosis Journal